Frontlight ResearchEarly access
Spinal muscular atrophy trials in Germany
5 of 7 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleStudy of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
- Where
- Essen
- Age
- 3 years and over
- People
- 90 worldwide
- Run by
- Alcyone Therapeutics, Inc
See details and how to joinNCT05866419 - Phase 3Not yet taking people in GermanyA Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
- Where
- Essen, Heidelberg, Ulm
- Age
- 0 days to 42 days
- People
- 30 worldwide
- Run by
- Biogen
See details and how to joinNCT07221669 · EU 2025-524054-34-00 - Phase 3Not yet taking people in GermanyA Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
- Where
- DO NOT EDIT
- Age
- 0 days to 7 months
- People
- 42 worldwide
- Run by
- Biogen
See details and how to joinNCT07444450 · EU 2025-523857-32-00 - Phase 1Not yet taking people in GermanyA Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
- Where
- Essen, Munich
- Age
- 3 years and over
- People
- 78 worldwide
- Run by
- Biogen
See details and how to joinNCT06555419 · EU 2024-514239-21-00 - No phaseEnrolling by invitationThe Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.
- Where
- Bad Feilnbach
- Age
- 65 years to 65 years
- People
- 30
- Run by
- LMU Klinikum
See details and how to joinNCT07072676